WEDNESDAY, April 9, 2025 (HealthDay News) — An experimental drug can help patients with advanced multiple sclerosis (MS) delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib, delayed disability progression by 31% in people with a type of MS called non-relapsing secondaryContinue Reading

FRIDAY, April 4, 2025 (HealthDay News) — Antidepressants appear to increase people’s risk of sudden cardiac death, a new study says. People taking the mood meds are more likely to die suddenly from heart problems, and their risk rises the longer they’re on the drugs, according to findings presented MondayContinue Reading